Related references
Note: Only part of the references are listed.Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation
Tiago Nava et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study
Marc Ansari et al.
ONCOTARGET (2017)
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation
Tiago Nava et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
M. Ansari et al.
BONE MARROW TRANSPLANTATION (2016)
The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients
Hong-Na Wang et al.
CLINICAL IMMUNOLOGY (2015)
Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation
Boyoon Choi et al.
PHARMACOGENOMICS (2015)
Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Patricia Huezo-Diaz et al.
CURRENT DRUG METABOLISM (2014)
Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients
M. Ansari et al.
BONE MARROW TRANSPLANTATION (2013)
The Interaction of the Chemotherapeutic Drug Chlorambucil with Human Glutathione Transferase A1-1: Kinetic and Structural Analysis
Michael Karpusas et al.
PLOS ONE (2013)
Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation
Marc Ansari et al.
THERAPEUTIC DRUG MONITORING (2013)
Influence of GST gene polymorphisms on busulfan pharmacokinetics in children
M. Ansari et al.
BONE MARROW TRANSPLANTATION (2010)
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa
Corine Ekhart et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric Patients
Juliette Zwaveling et al.
THERAPEUTIC DRUG MONITORING (2009)
Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis
Sarah L. Holley et al.
CARCINOGENESIS (2007)
Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apaptosis in Caco-2 cells
Laura Romero et al.
BIOCHEMICAL JOURNAL (2006)
Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment
C Sweeney et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver:: Consequences for enzyme expression and busulfan conjugation
M Bredschneider et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The human glutathione transferase alpha locus:: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter
F Morel et al.
PHARMACOGENETICS (2002)
Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression
BF Coles et al.
PHARMACOGENETICS (2001)
Polymorphism of human Alpha class glutathione transferases
N Tetlow et al.
PHARMACOGENETICS (2001)
Role of glutathione S-transferases in protection against lipid peroxidation -: Overexpression of hgsta2-2 in k562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation
Y Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
